Cite

HARVARD Citation

    Lecocq, H. et al. (2016). Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France. Vaccine. 34 (19), pp. 2240-2250. [Online]. 
  
Back to record